[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mineralocorticoid-excess\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mineralocorticoid-excess":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100396254","biomarkers-and-choroidal-neovascularization-100396254",false,"NCT04439708","Biomarkers and Choroidal Neovascularization","Biomarkers Analysis of Mineralocortoid Receptor Activation in the Serum and Ocular Fluid of Patients With Choroidal Neovascularization","BioNéoRet","Inclusion Criteria:\n\nPatients of group 1:\n\n* Patients with type 1 choroidal neovascularization in a context of central serous chorioretinoathy or age related macular degeneration\n* Patients without intravitreal injection or last intravitreal injection \\> 3 months\n* Informed signed consent\n\nPatients of group 2:\n\n* Patients without choroidal neovascularization\n* Patients with intraocular surgery (cataract or vitrectomy surgery)\n* Signed consent\n\nExclusion Criteria:\n\n* Myocardial infarction \\\u003C 12 months\n* Chronic renal failure\n* Inflammatory disease\n* Infectious disease :HIV, viral hepatitis, tuberculosis\n* Type 1 or 2 Diabetes\n* Patients treated by mineralocorticoid antagonist treatment.\n* Type 2 or 3 choroidal neovascularization\n* Pregnant woman","ALL","18 Years","90 Years",{"count":21,"type":22},250,"ESTIMATED","OBSERVATIONAL","The aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.",[26,27],"Choroidal Neovascularization","Mineralocorticoid Excess",[29,30,31],"central serous chorioretinopathy","age related macular degeneration","biomarker","RECRUITING","2026-07-03",{"date":35,"type":36},"2026-07-07","ACTUAL",{"date":38,"type":36},"2020-07-06",{"date":40,"type":22},"2027-07-06",{"name":42,"class":43},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":69},"100554199","dynamic-hormone-profiling-and-multimodal-data-capture-in-primary-aldosteronism-100554199","NCT06495983","Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism","Inclusion criteria Age 18 to 70 years Suspected PA admitted for diagnostic saline infusion testing or confirmed PA diagnosis according to Endocrine Society criteria.. Written informed consent\n\nExclusion criteria\n\n* Age \\\u003C18 or \\> 70 years.\n* Pregnancy.\n* Known adrenal failure and\u002For on steroid therapy (oral, inhaled, parenteral or topical) or other interfering medication.","70 Years",{"count":52,"type":22},80,"This study is a observational study applying 24-hour microdialysis methodology to perform dynamic multisteroid adrenal hormone profiling of patients with suspected or confirmed PA. Simultaneous registration of blood pressure, tissue glucose, sleep pattern, activity level and food intake registration may be performed. The overall objective is to develop a novel, sensitive, fast and user-friendly diagnostic procedure for PA, using multimodal data capture including dynamic multisteroid hormone profiling from microdialysis fluid.",[27,55,56],"Primary Aldosteronism","Hypercortisolism",[58],"aldosterone","2024-07-03",{"date":61,"type":36},"2024-07-11",{"date":63,"type":36},"2024-06-01",{"date":65,"type":22},"2028-12",{"name":67,"class":68},"Haukeland University Hospital","OTHER",1]